Page last updated: 2024-12-07

galactosylhydroxylysine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

galactosylhydroxylysine: found in collagen & basement membranes; presence in urine can be used to determine collagen metabolism [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123986
CHEBI ID37564
MeSH IDM0051238

Synonyms (13)

Synonym
32448-36-5
galactosylhydroxylysine
(2s)-2,6-diamino-5-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanoic acid
l-lysine, 5-(beta-d-galactopyranosyloxy)-
5-(beta-d-galactopyranosyloxy)-l-lysine
CHEBI:37564
5-(galactosylhydroxy)-l-lysine
AKOS027314097
(2s)-2,6-diamino-5-(((2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)hexanoic acid
DTXSID001314076
CS-0059366
HY-113230
PD020225

Research Excerpts

Overview

Galactosylhydroxylysine appears to be a sensitive index of bone resorption, useful in the clinical assessment of bone involvement and in the management of mild primary hyperparathyroidism.

ExcerptReferenceRelevance
"Galactosylhydroxylysine appears to be a sensitive index of bone resorption, useful in the clinical assessment of bone involvement and in the management of patients with mild primary hyperparathyroidism."( Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism.
Bertoldo, F; Bettica, P; Braga, V; LoCascio, V; Moro, L; Pasini, AF; Stefani, L, 1994
)
1.96

Dosage Studied

ExcerptRelevanceReference
" Accordingly, definite dose-response studies can now be done in a reasonable time."( Biochemical markers of bone turnover for the clinical assessment of bone metabolism.
Baylink, DJ; Libanati, C; Lueken, SA; Taylor, AK, 1994
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
5-glycosyloxy-L-lysine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (58)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (27.59)18.7374
1990's31 (53.45)18.2507
2000's8 (13.79)29.6817
2010's3 (5.17)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.26 (24.57)
Research Supply Index4.16 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (6.78%)5.53%
Reviews2 (3.39%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other53 (89.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]